Illumina (ILMN) is a publicly traded Healthcare sector company. As of October 3, 2026, ILMN trades at $273.83 with a market cap of $40.12B and a P/E ratio of 50.12. ILMN moved +2.75% today. Year to date, ILMN is +103.23%; over the trailing twelve months it is +174.97%. Its 52-week range spans $68.70 to $280.17. Analyst consensus is buy with an average price target of $200.88. Rallies surfaces ILMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Illumina (ILMN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ILMN moved +2.75% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $273.83 |
| Market Cap | $40.12B |
| P/E Ratio | 50.12 |
| EPS | $5.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $280.17 |
| 52-Week Low | $68.70 |
| Volume | 2.15M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.49B |
| Net Income | $824.00M |
| Gross Margin | 66.38% |
17 analysts cover ILMN: 0 strong buy, 9 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is buy. Average price target: $200.88.